Chen Lizhen, Yu Dayun, Ling Shuang, Xu Jin-Wen
Institute of Interdisciplinary Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Front Cardiovasc Med. 2022 Sep 12;9:988360. doi: 10.3389/fcvm.2022.988360. eCollection 2022.
According to traditional Chinese medicine (TCM), chronic heart failure has the basic pathological characteristics of "heart-kidney yang deficiency." Chronic heart failure with heart- and kidney-Yang deficiency has good overlap with New York Heart Association (NYHA) classes III and IV. Traditional Chinese medicine classical prescriptions for the treatment of chronic heart failure often take "warming and tonifying kidney-Yang" as the core, supplemented by herbal compositions with functions of "promoting blood circulation and dispersing blood stasis." Nowadays, there are still many classical and folk prescriptions for chronic heart failure treatment, such as Zhenwu decoction, Bushen Huoxue decoction, Shenfu decoction, Sini decoction, as well as Qili Qiangxin capsule. This review focuses on classical formulations and their active constituents that play a key role in preventing chronic heart failure by suppressing inflammation and modulating immune and neurohumoral factors. In addition, given that mitochondrial metabolic reprogramming has intimate relation with inflammation, cardiac hypertrophy, and fibrosis, the regulatory role of classical prescriptions and their active components in metabolic reprogramming, including glycolysis and lipid β-oxidation, is also presented. Although the exact mechanism is unknown, the classical TCM prescriptions still have good clinical effects in treating chronic heart failure. This review will provide a modern pharmacological explanation for its mechanism and offer evidence for clinical medication by combining TCM syndrome differentiation with chronic heart failure clinical stages.
根据中医理论,慢性心力衰竭具有“心肾阳虚”的基本病理特征。心肾阳虚型慢性心力衰竭与纽约心脏协会(NYHA)心功能Ⅲ级和Ⅳ级有较好的重叠。中医治疗慢性心力衰竭的经典方剂常以“温补肾阳”为核心,并辅以具有“活血化瘀”功效的中药组合物。目前,治疗慢性心力衰竭仍有许多经典方剂和民间验方,如真武汤、补肾活血汤、参附汤、四逆汤以及芪苈强心胶囊。本综述重点关注经典方剂及其活性成分,它们通过抑制炎症以及调节免疫和神经体液因子,在预防慢性心力衰竭中发挥关键作用。此外,鉴于线粒体代谢重编程与炎症、心脏肥大和纤维化密切相关,本文还介绍了经典方剂及其活性成分在包括糖酵解和脂质β-氧化在内的代谢重编程中的调节作用。尽管确切机制尚不清楚,但中医经典方剂在治疗慢性心力衰竭方面仍具有良好的临床效果。本综述将为其作用机制提供现代药理学解释,并通过将中医辨证与慢性心力衰竭临床分期相结合,为临床用药提供依据。